Back to results
US 12,338,220 B2Granted
Antiviral pyrazolopiridinone compounds
AssigneesGilead Sciences, Inc., Novartis AG
InventorsZef Konst, Yipin Lu, Robert Joseph Moreau, Naomi Samadara Rajapaksa, Galen Shearn-Nance, David Charles Tully, Michael Robert Turner, Joseph Michael Young, Qian Zhao, Britton K. Corkey, Samuel E. Metobo
Life of this patent
Estimating the term…
Abstract
The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.
Claims21
A compound of Formula (I), or a pharmaceutically acceptable salt thereof,
- wherein:
- X is
- a 5-6 membered heteroaryl having 1 to 4 heteroatoms independently selected from N, O and S as ring members, a 5-6 membered heterocycloalkyl containing 1 to 4 ring members independently selected from N, NH, NR17, O or S or a 5-6 membered heterocyclyl containing 1 to 4 ring members independently selected from N, NH, NR17, O or S;
- Y is a bond,
- —O— or
- wherein the * of Y indicates the point of attachment to X and the ** of Y indicates the point of attachment to RB;
- q is 1;
- LMC is *—((CR11R12)nO)m(CR11R12)p**, *—C(═O)NR15((CR11R12)nO)m(CR1R12)—*, *—(CR11R12)nNR15((CR11R12)nO)m(CR11R12)p**, *—(CR11R12)n—**, *—((CR11R12)nNR15)m(CR1R12)p**, *—(CR1R12)C(═O)NR15(CR11R12)n—**, —C(═O)NR15(CR11 R12)n—**, *—O(CR1R12)n—**, or *—NR15(CR1R12)n—**, wherein the * of LMc indicates the point of attachment to Z and the ** of LMC indicates the point of attachment to A;
- A is a bond and Z is
- wherein the * of Z indicates the point of attachment to LMC and the ** of Z indicates the point of attachment to L;
- m is 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10;
- each n is independently selected from 1, 2, 3, 4, 5, 7, 8, 9 and 10;
- p is 1, 2, 3, 4, 5 or 6;
- RB is H, C1-C6 alkyl, phenyl, pyridinyl, thiophenyl, pyrimidinyl, or a 5-8 membered cycloalkyl, wherein RB is optionally substituted with 1 to 3 R5 groups;
- R1 is selected from H, C1-C3 alkyl and C1-C3 alkyl substituted with 1 to 3 —OH groups;
- R2 is selected from H, C1-C3 alkyl and C1-C3 alkyl substituted with 1 to 3 —OH groups;
- or R1 and R2 taken together with the carbon to which they are attached can form a 3-6 membered cycloalkyl ring;
- t is 0, 1 or 2;
- each R3, when present, is a substituent on the ring to which -L-Z is directly attached, wherein each R3 is independently selected from halo, CN, C1-C3 alkoxy, C1-C3 alkyl, C(═O)OR10, and C(═O)NR13R14;
- each R5 is independently selected from halo, —CN, hydroxy, —NR13R14, C3-C6 cycloalkyl, C1-C3 alkoxy, C1-C3haloalkyl, and C1-C3 alkyl optionally substituted with 1 to 3 R6 groups, wherein when RB is substituted with two R5 and each R5 is a C1-C3 alkyl optionally substituted with 1 to 3 R6 groups, when directly attached to the same carbon atom, may be taken together with the carbon to which both are directly attached to form a 3-5 membered cycloalkyl ring optionally substituted with 1 to 3 R6 groups;
- each R6 is independently selected from halo, hydroxy, CN, C1-C3 alkoxy, C1-C3 alkyl, and C3-C5 cycloalkyl,
- or two R6 groups, taken together with a carbon atom to which both are directly attached may form a 3-5 membered cycloalkyl ring or a 4-6 membered heterocyclic ring containing O, N or S as a ring member and optionally substituted with 1 to 2 groups independently selected from oxo and C1-C3 alkyl;
- L is a C1-C4 straight chain or branched alkylene linker;
- R10 is selected from C1-C5 alkyl, C1-C3haloalkyl, 3-6 membered cycloalkyl, phenyl, 5-6 membered heteroaryl having 1 to 4 heteroatoms independently selected from N, O and S as ring members, 4-6 membered heterocycloalkyl containing one or two ring members independently selected from N, NH, NR17, O or S and 4-6 membered heterocyclyl containing 1 to 2 ring members independently selected from N, NH, NR17, O or S,
- wherein each R10 is optionally substituted with 1 to 5 groups independently selected from C1-C4 alkyl, deuterium, C1-C4haloalkoxy, -L3OH, -L3CN, -L3OC(═O)R14, -L3OR13, C1-C2haloalkyl, oxo, -L3 halo, -L3C1-C3 alkoxy, -L3OC(═O)NR13R14, -L3SO2R13, -L3SO2NR13R14, -L3SO2NR13C(═O)R13, -L3C(═O)NR13SO2R13, -L3S(═O)R13, -L3S(═O)(=NR14)R13, -L3NR13SO2NR13R14, -L3NR13SO2R13, -L3NR13R14, -L3NR14C(═O)R13, -L3NR14C(═O)OR13, -L3C(═O)NR13R14, -L3C(═O)OR13, -L3-(4-7-membered heterocycloalkyl containing 1 to 2 ring members independently selected from N, NH, NR17, O or S), -L3-(4-7-membered heterocyclyl containing 1 to 2 ring members independently selected from N, NH, NR17, O or S), -L3-C3-C5 cycloalkyl, and -L3-(5-6 membered heteroaryl ring having 1 to 4 heteroatoms comprising 1-4 nitrogen atoms, 0 or 1 oxygen atoms, and 0 or 1 sulfur atoms as ring members), where the C1-C4 alkyl, 4-7-membered heterocycloalkyl, 4-7-membered heterocyclyl, C3-C5 cycloalkyl and 5-6 membered heteroaryl ring are each optionally further substituted with 1 to 3 groups independently selected from halo, C1-C3 alkyl, C1-C3haloalkyl, -L4OR13, -L4CN, and -L4NR13R14;
- R11 and R12 are each independently selected from H and C1-C4 alkyl;
- each R13 is independently selected from H, C1-C4 alkyl, a 4-7-membered heterocycloalkyl containing 1 to 2 ring members independently selected from N, NH, NR17, O or S, a 4-7-membered heterocyclyl containing 1 to 2 ring members independently selected from N, NH, NR17, O or S, and a C3-C6 cycloalkyl, wherein the C1-C4 alkyl, heterocycloalkyl, heterocyclyl and C3-C6 cycloalkyl are optionally substituted with 1 to 3 groups independently selected from C1-C4 alkyl, halo, —OH, —NR15R16, —C(═O)OR15, C1-C2 alkoxy and C1-C4 alkyl substituted with 1 to 2 hydroxy groups;
- R14 is selected from H, C1-C4 alkyl and C3-C6 cycloalkyl, wherein the C1-C4 alkyl and C3-C6 cycloalkyl are optionally substituted with 1 to 3 groups independently selected from C1-C4 alkyl, halo, —OH, —NR15R16, C1-C2 alkoxy and C1-C4 alkyl substituted with 1 to 2 hydroxy groups;
- or R13 and R14, taken together with a nitrogen atom to which both are directly attached, can form a 4-6 membered ring optionally containing an additional N, O or S as a ring member and optionally substituted with one to three groups selected from C1-C2 alkyl, C1-C2 alkoxy, oxo, and hydroxy;
- R15 and R16 are each independently selected from H and C1-C4 alkyl;
- each R17 is independently selected from H, C1-C4 alkyl and C3-C8 cycloalkyl,
- or R17 is C1-C4 alkyl which, together with a nitrogen atom to which it is directly attached, and a nitrogen atom from the pyrazole ring, can form a 5-8 membered ring fused to the pyrazole ring;
- each L3 and L4 is independently a bond or a straight chain or branched C1-C3alkylene;
- and
- represents a single or double bond.
32 more elements
Dependencies are inferred from the claim text.